BACE: Therapeutic target and potential biomarker for Alzheimer's disease.

[1]  Christopher G. Wilson,et al.  BACE1 Deficiency Causes Altered Neuronal Activity and Neurodegeneration , 2010, The Journal of Neuroscience.

[2]  G. Tesco,et al.  Ubiquitin Regulates GGA3-mediated Degradation of BACE1* , 2010, The Journal of Biological Chemistry.

[3]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[4]  P. Wong,et al.  The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential , 2009, The Journal of Neuroscience.

[5]  A. Turner,et al.  Cell biology, regulation and inhibition of β‐secretase (BACE‐1) , 2009, The FEBS journal.

[6]  Marc Tessier-Lavigne,et al.  APP binds DR6 to trigger axon pruning and neuron death via distinct caspases , 2009, Nature.

[7]  J. Stockley,et al.  Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease , 2008, Cellular and Molecular Life Sciences.

[8]  M. Wolfe,et al.  Promotion of BACE1 mRNA Alternative Splicing Reduces Amyloid β-Peptide Production* , 2008, Journal of Biological Chemistry.

[9]  D. Price,et al.  Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice , 2008, Proceedings of the National Academy of Sciences.

[10]  G. Evin,et al.  BACE inhibitors as potential therapeutics for Alzheimer's disease. , 2007, Recent patents on CNS drug discovery.

[11]  P. Wong,et al.  Bace1 modulates myelination in the central and peripheral nervous system , 2006, Nature Neuroscience.

[12]  Colin L Masters,et al.  Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. , 2006, Brain : a journal of neurology.

[13]  J. Walter.  Control of Amyloid-β-Peptide Generation by Subcellular Trafficking of the β-Amyloid Precursor Protein and β-Secretase , 2006, Neurodegenerative Diseases.

[14]  Inder M Verma,et al.  Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model , 2005, Nature Neuroscience.

[15]  Wanpin Chang,et al.  GGA Proteins Mediate the Recycling Pathway of Memapsin 2 (BACE)* , 2005, Journal of Biological Chemistry.

[16]  B. Hyman,et al.  Beta-secretase activity increases with aging in human, monkey, and mouse brain. , 2004, The American journal of pathology.

[17]  M. Ohno,et al.  BACE1 Deficiency Rescues Memory Deficits and Cholinergic Dysfunction in a Mouse Model of Alzheimer's Disease , 2004, Neuron.

[18]  Colin L Masters,et al.  Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets , 2003, Journal of neuroscience research.

[19]  M. Pangalos,et al.  BACE1 (β-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes , 2003, Molecular and Cellular Neuroscience.

[20]  N. Hooper,et al.  Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Wong,et al.  Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease , 2003, Nature Medicine.

[22]  B. Hyman,et al.  Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. , 2002, Archives of neurology.

[23]  C. Masters,et al.  Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease , 2002 .

[24]  R. Vassar.  The beta-secretase, BACE: a prime drug target for Alzheimer's disease. , 2001, Journal of molecular neuroscience : MN.

[25]  G. Multhaup,et al.  A Splice Variant of β-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor Protein* , 2001, The Journal of Biological Chemistry.

[26]  L Hong,et al.  Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. , 2000, Science.

[27]  M. Citron,et al.  Expression Analysis of BACE2 in Brain and Peripheral Tissues* , 2000, The Journal of Biological Chemistry.

[28]  J. Tang,et al.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[30]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[31]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[32]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.